Alderson M R, Armitage R J, Tough T W, Strockbine L, Fanslow W C, Spriggs M K
Department of Cellular Immunology, Immunex Research and Development Corporation, Seattle, Washington 98101.
J Exp Med. 1993 Aug 1;178(2):669-74. doi: 10.1084/jem.178.2.669.
CD40 is a member of the tumor necrosis factor (TNF) receptor family of cell surface proteins and was originally described as a B cell restricted antigen. Treatment of primary human monocytes with granulocyte/macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3), or interferon gamma (IFN-gamma) resulted in the induction of CD40 mRNA and enhancement of cell surface protein expression. CD40 was found to mediate monocyte adhesion to cells expressing recombinant CD40 ligand. CD40 ligand-transfected cells provided a potent costimulus for monocyte TNF-alpha and IL-6 production in the presence of GM-CSF, IL-3, or IFN-gamma, and enhanced IL-8 production stimulated by GM-CSF or IL-3. In addition, CD40 ligand-transfected cells acting in the absence of a costimulus induced monocytes to become tumoricidal against a human melanoma cell target. Collectively, these data indicate that CD40 ligand is pleiotropic with potent biological activity on monocytes.
CD40是细胞表面蛋白肿瘤坏死因子(TNF)受体家族的成员,最初被描述为B细胞限制性抗原。用粒细胞/巨噬细胞集落刺激因子(GM-CSF)、白细胞介素3(IL-3)或干扰素γ(IFN-γ)处理原代人单核细胞,会导致CD40 mRNA的诱导和细胞表面蛋白表达的增强。发现CD40介导单核细胞与表达重组CD40配体的细胞的粘附。在存在GM-CSF、IL-3或IFN-γ的情况下,转染CD40配体的细胞为单核细胞TNF-α和IL-6的产生提供了强大的共刺激,并增强了由GM-CSF或IL-3刺激的IL-8产生。此外,在没有共刺激的情况下起作用的转染CD40配体的细胞诱导单核细胞对人黑色素瘤细胞靶标具有杀肿瘤作用。总体而言,这些数据表明CD40配体具有多效性,对单核细胞具有强大的生物学活性。